15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
On August 8, 2019, India’s new Code on Wages (Code) received the Presidential assent and was notifi...
Read More >
In a split decision, the National Labor Relations Board (NLRB or the Board) ruled last week that a p...
Read More >
COVID-19 has led to a new situation in Spain. But deals are still closing. Further to the national ...
Read More >
We highlight the responses companies are taking in light of the current environment and the argument...
Read More >
This week, over a five-part podcast series, we have considered some of the basic questions around mo...
Read More >
On October 12, 2020, in Travelport Ltd & Ors v WEX Inc [2020] EWHC 2670, Justice Cockerill of the En...
Read More >